Metabolic Syndrome in HIV-patients in Antiretroviral Therapy
| Autor: | Leonardo Bispo Pires, Helma Pinchemel Cotrim, Vitor Hugo Moreau Da Cunha, Carlos Brites, Vitor Coelho, Daniel Vargas-Pacherrez, Carla Daltro |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Multivariate analysis Anti-HIV Agents HIV Infections Overweight 03 medical and health sciences 0302 clinical medicine Acquired immunodeficiency syndrome (AIDS) Virology Diabetes mellitus Internal medicine Antiretroviral Therapy Highly Active medicine Prevalence Humans 030212 general & internal medicine Family history Metabolic Syndrome 0303 health sciences Acquired Immunodeficiency Syndrome 030306 microbiology business.industry Hypertriglyceridemia Middle Aged medicine.disease Antiretroviral therapy Infectious Diseases Cross-Sectional Studies Female medicine.symptom Metabolic syndrome business Brazil |
| Zdroj: | Current HIV research. 18(6) |
| ISSN: | 1873-4251 |
| Popis: | Introduction: The global prevalence of metabolic syndrome (MS) among people living with HIV/AIDS varies from 20% to 33%. Objective: to estimate the prevalence of metabolic syndrome and associated factors in a group of HIV-infected patients on antiretroviral therapy. Methods: This is a cross-sectional study with HIV-infected patients from a reference center in Bahia, Brazil. We evaluated clinical, socio-demographic and anthropometric data. MS was defined according to the guidelines of International Diabetes Federation. Results: We evaluated 152 patients with mean age of 47.3±11.6 years, 59.2% male. The main comorbidities detected were diabetes (3.3%) hypertriglyceridemia (9.3%) and metabolic syndrome (MS,38.2%). Patients with MS were predominantly women (55.2% vs 31.9%; p=0.005), older [52.1 (10.4) vs 44.3 (11.3); p Conclusion: Almost half of the HIV-infected patients in Bahia presents with MS which seems to be driven by classical risk factors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|